➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Johnson and Johnson

Last Updated: September 16, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072210

Email this page to a colleague

« Back to Dashboard

NDA 072210 describes PANCURONIUM BROMIDE, which is a drug marketed by Dr Reddys, Elkins Sinn, Hospira, and Igi Labs Inc, and is included in eleven NDAs. It is available from one supplier. Additional details are available on the PANCURONIUM BROMIDE profile page.

The generic ingredient in PANCURONIUM BROMIDE is pancuronium bromide. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pancuronium bromide profile page.
Summary for 072210
Applicant:Igi Labs Inc
Ingredient:pancuronium bromide
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 072210

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength1MG/ML
Approval Date:Mar 31, 1988TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.